Human LILRA2, recombinant (C-6His)

Human LILRA2, recombinant (C-6His)
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
NOV-CA47.10ug 10 µg - -

10 - 15 Werktage*

105,00 €
NOV-CA47.50ug 50 µg - -

10 - 15 Werktage*

315,00 €
NOV-CA47.500ug 500 µg - -

10 - 15 Werktage*

1.540,00 €
NOV-CA47.1mg 1 mg - -

10 - 15 Werktage*

2.200,00 €
 
Recombinant Human Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 2 is produced by our... mehr
Produktinformationen "Human LILRA2, recombinant (C-6His)"
Recombinant Human Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 2 is produced by our Mammalian expression system and the target gene encoding Gly24-Ser420 is expressed with a 6His tag at the C-terminus. Protein function: Part of the innate immune responses against microbial infection (PubMed:12529506, PubMed:27572839). Specifically recognizes a set of N-terminally truncated immunoglobulins that are produced via cleavage by proteases from a range of pathogenic bacteria and fungi, including L.pneumophila, M.hyorhinis, S.pneumoniae, S.aureus and C.albicans (PubMed:27572839). Recognizes epitopes that are in part in the variable region of the immunoglobulin light chains, but requires also the constant region for signaling (PubMed:27572839). Binds to a subset of cleaved IgM, IgG3 and IgG4 molecules, but does not bind cleaved IgA1 (PubMed:27572839). Binding of N-terminally truncated immunoglobulins mediates activation of neutrophils (PubMed:27572839). In monocytes, activation leads to the release of CSF2, CF3, IL6, CXCL8 and CCL3 and down-regulates responses to bacterial lipopolysaccharide (LPS), possibly via down-regulation of TLR4 expression and reduced signaling via TLR4 (PubMed:22479404). In eosinophils, activation by ligand binding leads to the release of RNASE2, IL4 and leukotriene C4 (PubMed:12529506). Does not bind class I MHC antigens (PubMed:19230061). [The UniProt Consortium]
Schlagworte: ILT1, ILT-1, CD85h, LIR-7, LILRA2, Immunoglobulin-like transcript 1, CD85 antigen-like family member H, Leukocyte immunoglobulin-like receptor 7, Leukocyte immunoglobulin-like receptor subfamily A member 2, Recombinant Human LILRA2 (C-6His)
Hersteller: Novoprotein
Hersteller-Nr: CA47

Eigenschaften

Konjugat: No
Wirt: Human cells
Spezies-Reaktivität: human
MW: 44.8 kD
Format: Lyophilized

Datenbank Information

KEGG ID : K06512 | Passende Produkte
UniProt ID : Q8N149 | Passende Produkte

Handhabung & Sicherheit

Lagerung: -20°C (+4 °C for short term storage)
Versand: +20°C (International: +20°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier folgen Informationen zur Produktreferenz. mehr
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Human LILRA2, recombinant (C-6His)"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen